[go: up one dir, main page]

ES8605644A1 - Procedimiento para la preparacion de un suero de control o calibrado - Google Patents

Procedimiento para la preparacion de un suero de control o calibrado

Info

Publication number
ES8605644A1
ES8605644A1 ES549777A ES549777A ES8605644A1 ES 8605644 A1 ES8605644 A1 ES 8605644A1 ES 549777 A ES549777 A ES 549777A ES 549777 A ES549777 A ES 549777A ES 8605644 A1 ES8605644 A1 ES 8605644A1
Authority
ES
Spain
Prior art keywords
lipid
control
serum
diagnostics
standard
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES549777A
Other languages
English (en)
Other versions
ES549777A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6252384&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8605644(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES8605644A1 publication Critical patent/ES8605644A1/es
Publication of ES549777A0 publication Critical patent/ES549777A0/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165—Lipid, cholesterol, or triglyceride standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN SUERO DE CONTROL O CALIBRADO. COMPRENDE: A) CONCENTRAR UNA SOLUCION DE SUERO HUMANO, PARA AJUSTAR LOS PARAMETROS RELEVANTES DEL DIAGNOSTICO DE LIPIDOS EN EL MARGEN NORMAL O PATOLOGICO DE CONCENTRACIONES; B) MEZCLAR AL CONCENTRADO DE A) CON AGENTES AUXILIARES; C) FILTRAR A LA MEZCLA DE B) A TRAVES DE UN FILTRO DE MEMBRANA (ANCHURA DE MALLAS H 2 MM); D) ENVASAR AL FILTRADO EN FRASQUITOS DE TAMAÑO (1 A 5 ML DE CAPACIDAD); Y E) LIOFILIZAR A LOS ENVASES A 4JC. LOS PARAMETROS RELEVANTES SON HDL-COLESTERINA, LDL-COLESTERINA, TRIGLICERIDOS, Y APOLIPO-PROTEINAS A1, A2 Y B; LOS AGENTES AUXILIARES SON AGENTES ACLARADORES O ABRILLANTADORES COMO PENTAERITRITOL, AGENTES ESTABILIZANTES COMO AZUCARES (SACAROSA) Y CONSERVANTES COMO AZIDAS, MERTIOLATO Y ANTIBIOTICOS, Y EL SUERO HUMANO SE ELIGE ENTRE SUERO HUMANO RECIENTEMENTE RECOGIDO Y PLASMA HUMANO RECIENTEMENTE RECOGIDO QUE SE TRANSFORMA EN SUERO HUMANO.
ES549777A 1984-12-10 1985-12-10 Procedimiento para la preparacion de un suero de control o calibrado Expired ES8605644A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843445010 DE3445010A1 (de) 1984-12-10 1984-12-10 Kontroll- bzw. eichserum fuer die lipid-diagnostik

Publications (2)

Publication Number Publication Date
ES8605644A1 true ES8605644A1 (es) 1986-04-01
ES549777A0 ES549777A0 (es) 1986-04-01

Family

ID=6252384

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549777A Expired ES8605644A1 (es) 1984-12-10 1985-12-10 Procedimiento para la preparacion de un suero de control o calibrado

Country Status (6)

Country Link
US (1) US4701417A (es)
EP (1) EP0184765B1 (es)
JP (1) JPS61142467A (es)
AT (1) ATE63168T1 (es)
DE (2) DE3445010A1 (es)
ES (1) ES8605644A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593894A (en) * 1990-01-11 1997-01-14 Research Corporation Technologies, Inc. Direct cholesterol assay
US5547873A (en) * 1994-02-22 1996-08-20 Genzyme Corporation Compositions for stabilizing proteins for long term dry storage and methods of making and using the compositions
US5621094A (en) * 1990-05-14 1997-04-15 Quadrant Holdings Cambridge Limited Method of preserving agarose gel structure during dehydration by adding a non-reducing glycoside of a straight-chain sugar alcohol
DE4135404A1 (de) * 1991-10-26 1993-04-29 Boehringer Mannheim Gmbh Stabiles fluessiges kontroll- bzw. eichserum fuer die klinische diagnostik
EP0679088B1 (en) 1992-09-29 2002-07-10 Inhale Therapeutic Systems Pulmonary delivery of active fragments of parathyroid hormone
AT399056B (de) * 1993-03-19 1995-03-27 Immuno Ag Lyophilisiertes kontroll- oder referenzplasma bzw. kontroll- oder referenzserum für diagnostische zwecke
DE69535897D1 (de) 1994-03-07 2009-01-22 Nektar Therapeutics Verfahren und Zusammensetzung für die pulmonale Darreichung von Insulin
US5955448A (en) 1994-08-19 1999-09-21 Quadrant Holdings Cambridge Limited Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
DE69530196T2 (de) * 1994-06-02 2003-11-20 Elan Drug Delivery Ltd Methode zum verhindern der aggregation von proteinen/peptiden bei rehydratation oder auftauen
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
CA2197437A1 (en) * 1994-08-31 1996-03-07 Thomas H. Duffy Stable substitute tryglycerides for use in clinical chemistry assay controls or calibrators and process for their preparation
AU3570495A (en) 1994-09-22 1996-04-09 Quadrant Holdings Cambridge Limited Compositions for use in rehydration and nutrition during athletic exercise and methods of making same
EP0795134B1 (en) * 1994-11-28 2002-08-28 Abbott Laboratories Stabilized aqueous steroid immunoassay standards
US5614414A (en) * 1995-03-30 1997-03-25 Streck Laboratories, Inc. Liquid lipoprotein control
US5770451A (en) * 1995-03-30 1998-06-23 Streck Laboratories, Inc. Liquid lipoprotein control
US6964771B1 (en) * 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
DE19654266A1 (de) * 1996-12-23 1998-06-25 Albrecht Prof Dr Wendel Untersuchungsverfahren mit biologischem System
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
AU2002349870A1 (en) * 2001-02-05 2003-04-01 The Board Of Regents For Oklahoma State University Direct serum lipids assays for evaluation of disease states
JP4574066B2 (ja) * 2001-06-06 2010-11-04 積水メディカル株式会社 Ｐｒｅβ１−ＨＤＬ測定用血液検体
MXPA04005865A (es) 2001-12-19 2004-09-13 Nektar Therapeutics Suministro de aminoglucosidos a los pulmones.
US7338802B2 (en) * 2002-10-30 2008-03-04 Radiometer Medical Aps Method of performing calibration and quality control of a sensor and apparatus for performing the method
US20050100636A1 (en) * 2003-11-10 2005-05-12 Megan Botteri [A Low-Calorie Sports Drink For Physically Active Women That is Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Replacing Electrolytes Lost During Periods of Physical Activity]
EP1794596B1 (en) * 2004-09-01 2013-11-06 Maine Standards Company LLC Novel stable lipid standards
JP4704355B2 (ja) * 2004-11-17 2011-06-15 協和メデックス株式会社 リポ蛋白中成分の分別定量用標準品
JP5596964B2 (ja) * 2008-12-02 2014-09-24 協和メデックス株式会社 リポ蛋白中成分の分別定量用標準品の製造方法
JP5728488B2 (ja) * 2009-11-13 2015-06-03 ビージー メディシン， インコーポレイテッド 心筋梗塞のリスクファクターおよび予測
CN114279778A (zh) * 2021-12-04 2022-04-05 南京岚煜生物科技有限公司 一种复合高值参考品的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876375A (en) * 1971-11-22 1975-04-08 Jonas Maurukas Biological composition for use as a reference control in diagnostic analysis
US3955925A (en) * 1973-11-12 1976-05-11 Proksch Gary J Preparation of optically clear serum
US4011045A (en) * 1975-02-14 1977-03-08 Bonderman Dean P Turbidity reduction in triglyceride standards
US4039285A (en) * 1975-10-10 1977-08-02 Ortho Diagnostics, Inc. Single sample method for determination of lipoprotein concentrations in blood
US4105521A (en) * 1977-09-21 1978-08-08 Helena Laboratories Corporation Clinical procedure for measuring lipoprotein cholesterols
US4226713A (en) * 1978-04-24 1980-10-07 Goldberg Jack M Diagnostic agents
US4216117A (en) * 1978-05-15 1980-08-05 Bonderman Dean P Lipoprotein diluent or solution and method useful in the preparation of assay reference materials
DE2839433A1 (de) * 1978-09-11 1980-03-20 Merck Patent Gmbh Waessrige lipid-standardloesung und verfahren zu ihrer herstellung
US4210557A (en) * 1978-12-15 1980-07-01 Beckman Instruments, Inc. Non-high density lipoprotein precipitant
US4290774A (en) * 1980-01-07 1981-09-22 Miles Laboratories, Inc. Purification of lipoprotein cholesterol for use as a cholesterol reference material
DE3007764A1 (de) * 1980-02-29 1981-10-15 Boehringer Mannheim Gmbh Verfahren und reagens zur bestimmung der beta -lipoproteine
JPS5836954B2 (ja) * 1980-03-31 1983-08-12 栄研化学株式会社 酵素の安定化剤
DE3107060A1 (de) * 1981-02-25 1982-09-09 Boehringer Mannheim Gmbh, 6800 Mannheim Kontroll- oder eichserum und verfahren zu seiner herstellung
DE3133937A1 (de) * 1981-08-27 1983-03-17 Boehringer Mannheim Gmbh Verfahren zur bestimmung von ldl
US4438202A (en) * 1981-11-30 1984-03-20 Technicon Instruments Corporation Stable, base serum compositions and preparation thereof

Also Published As

Publication number Publication date
DE3445010A1 (de) 1986-06-19
ATE63168T1 (de) 1991-05-15
JPS61142467A (ja) 1986-06-30
EP0184765B1 (de) 1991-05-02
US4701417A (en) 1987-10-20
EP0184765A3 (en) 1988-03-30
EP0184765A2 (de) 1986-06-18
DE3582723D1 (de) 1991-06-06
ES549777A0 (es) 1986-04-01
JPH0471468B2 (es) 1992-11-13

Similar Documents

Publication Publication Date Title
ES8605644A1 (es) Procedimiento para la preparacion de un suero de control o calibrado
AU553823B2 (en) Dental remineralication composition containing 2 phosph one-butane-tricarboxylic acid 1,2,4
ES545899A0 (es) Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disodico
GB8729216D0 (en) Distance sensing e.g.for active clearance control
OA08640A (en) Determination of clinical parameters by enzyme immunoprocess.
IT8484141A0 (it) Procedimento per la separazione dell'arsenico da soluzioni acide che lo contengono.
AU547620B2 (en) Valve for multiple blood sample assembly
FI853255A7 (fi) Menetelmä 6-kloori-N-metyyli-2,3,4,5 -tetrahydro-1H-3-bentsatsepiinin valmistamiseksi.
IT8021972A0 (it) Procedimento per la preparazione di n-fosfonometil glicina.
ES457940A1 (es) Procedimiento de preparacion de una sustancia alimenticia o dietetica.
DE3854084D1 (de) Serumvorbehandlung für testverfahren zur bestimmung des vitamins b12.
IT8523026A0 (it) Procedimento per la fabbricazione di coperchi valvole di compressori.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO853066L (no) Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
EP0049078A3 (en) Glutathione peroxidase, process for production thereof, method and composition for the quantitative determination of lipid peroxide
NO160205C (no) Fremgangsmaate ved fremstilling av silibininderivater.
NO159080C (no) Fremgangsmaate til fremstilling av 2,4-diklor-5-fluor-benzosyre.
NO874888D0 (no) Fremgangsmaate til fremstilling av aminometyl-5,6,7,8-tetrahydronaftyloksyeddiksyrer.
IT8424225A0 (it) Procedimento per la pesatura automatizzata.
EP0352026A3 (en) A glass slide useful as a control of standard by having several areas of differing levels or types of analytes, and devices and methods for preparing the same
NO893623L (no) Mikrobiologisk fremgangsmaate ved fremstilling av agrarkjemisk anvendelige virkestoffer.
IT1218692B (it) Procedimento microbiologico per la preparazione di 9 alfa-idrossi-4-androstene-3,17 dione
NO167788C (no) Fremgangsmaate for fremstilling av pastaer.
ES533079A0 (es) Procedimiento para la determinacion cuantitativa de la enzima c1 esterasa.
AU551250B2 (en) Preparation of satietin

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612